5AM Ventures V, L.P.
Insider CIK 1674324 · IMPL 10% owner · TRDA 10% owner · AKUS 10% owner · RLYB 10% owner · CABA 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-08-07 | 2026-08-10 | 52,317 | $6.85 | $358.4K | 2,783,781 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-08-07 | 2026-08-10 | 52,317 | $6.85 | $358.4K | 2,783,781 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-08-06 | 2026-08-10 | 10,494 | $7.00 | $73.5K | 2,836,098 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-08-06 | 2026-08-10 | 10,494 | $7.00 | $73.5K | 2,836,098 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-07-31 | 2026-08-03 | 1,718 | $6.85 | $11.8K | 2,846,592 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-07-31 | 2026-08-03 | 1,718 | $6.85 | $11.8K | 2,846,592 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-07-30 | 2026-08-03 | 114,756 | $6.93 | $795.3K | 2,848,310 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-07-30 | 2026-08-03 | 114,756 | $6.93 | $795.3K | 2,848,310 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2025-11-14 | 2025-11-18 | 200,000 | $8.80 | $1.76M | 2,963,066 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2025-07-09 | 2025-07-11 | 6,935 | $7.50 | $52.0K | 1,093,313 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2025-07-09 | 2025-07-11 | 20,065 | $7.50 | $150.5K | 3,163,066 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2025-07-01 | 2025-07-01 | 18,578 | $7.12 | $132.3K | 3,183,131 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2025-07-01 | 2025-07-01 | 6,422 | $7.12 | $45.7K | 1,100,248 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2025-06-30 | 2025-07-01 | 6,422 | $6.81 | $43.7K | 1,106,670 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2025-06-30 | 2025-07-01 | 18,578 | $6.81 | $126.5K | 3,201,709 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2025-06-27 | 2025-07-01 | 19,265 | $6.91 | $133.1K | 1,113,092 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2025-06-27 | 2025-07-01 | 55,735 | $6.91 | $385.1K | 3,220,287 | SEC↗ |
| RLYB Rallybio Corp | S Sale | 2023-03-07 | 2023-03-09 | 100,000 | $8.20 | $820.0K | 2,378,969 | SEC↗ |
| AKUS Akouos, Inc. | U Tender | 2022-11-30 | 2022-12-02 | 982,453 | — | $0 | 0 | SEC↗ |
| AKUS Akouos, Inc. | U Tender | 2022-11-30 | 2022-12-02 | 3,153,333 | — | $0 | 0 | SEC↗ |
| RLYB Rallybio Corp | S Sale | 2022-06-03 | 2022-06-07 | 99,671 | $12.50 | $1.25M | 2,478,969 | SEC↗ |
| RLYB Rallybio Corp | S Sale | 2022-06-03 | 2022-06-07 | 50,329 | $12.50 | $629.1K | 1,251,755 | SEC↗ |
| RLYB Rallybio Corp | S Sale | 2022-05-23 | 2022-05-25 | 66,447 | $13.00 | $863.8K | 2,578,640 | SEC↗ |
| RLYB Rallybio Corp | S Sale | 2022-05-23 | 2022-05-25 | 33,553 | $13.00 | $436.2K | 1,302,084 | SEC↗ |
| RLYB Rallybio Corp | S Sale | 2022-02-08 | 2022-02-10 | 70,461 | $13.05 | $919.5K | 1,335,637 | SEC↗ |
| RLYB Rallybio Corp | S Sale | 2022-02-08 | 2022-02-10 | 139,539 | $13.05 | $1.82M | 2,645,087 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | C Conversion deriv | 2021-11-02 | 2021-11-04 | 2,305,473 | — | $0 | 0 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | C Conversion deriv | 2021-11-02 | 2021-11-04 | 17,161,644 | — | $0 | 0 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | C Conversion deriv | 2021-11-02 | 2021-11-04 | 4,082,613 | — | $0 | 0 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | C Conversion deriv | 2021-11-02 | 2021-11-04 | 1,841,620 | — | $0 | 0 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | C Conversion deriv | 2021-11-02 | 2021-11-04 | 2,302,026 | — | $0 | 0 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | P Buy | 2021-11-02 | 2021-11-04 | 250,000 | $20.00 | $5.00M | 1,132,357 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | C Conversion | 2021-11-02 | 2021-11-04 | 318,140 | — | $0 | 882,357 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | C Conversion | 2021-11-02 | 2021-11-04 | 254,512 | — | $0 | 3,276,022 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | C Conversion | 2021-11-02 | 2021-11-04 | 564,217 | — | $0 | 564,217 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | C Conversion | 2021-11-02 | 2021-11-04 | 2,371,739 | — | $0 | 3,021,510 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | C Conversion | 2021-11-02 | 2021-11-04 | 318,616 | — | $0 | 649,771 | SEC↗ |
| CABA Cabaletta Bio, Inc. | S Sale | 2021-11-01 | 2021-11-03 | 36,544 | $13.00 | $475.1K | 333,144 | SEC↗ |
| CABA Cabaletta Bio, Inc. | S Sale | 2021-11-01 | 2021-11-03 | 258,456 | $13.00 | $3.36M | 1,731,119 | SEC↗ |
| CABA Cabaletta Bio, Inc. | S Sale | 2021-09-07 | 2021-09-09 | 625,000 | $9.70 | $6.06M | 1,989,575 | SEC↗ |
| RLYB Rallybio Corp | P Buy | 2021-08-02 | 2021-08-04 | 615,384 | $13.00 | $8.00M | 1,406,098 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | C Conversion deriv | 2021-04-27 | 2021-04-29 | 5,876,034 | — | $0 | 0 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | C Conversion deriv | 2021-04-27 | 2021-04-29 | 13,233,885 | — | $0 | 0 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | C Conversion deriv | 2021-04-27 | 2021-04-29 | 8,845,942 | — | $0 | 0 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | C Conversion deriv | 2021-04-27 | 2021-04-29 | 8,201,930 | — | $0 | 0 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | C Conversion deriv | 2021-04-27 | 2021-04-29 | 1,359,799 | — | $0 | 0 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | C Conversion | 2021-04-27 | 2021-04-29 | 358,878 | — | $0 | 2,208,334 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | P Buy | 2021-04-27 | 2021-04-29 | 575,000 | $15.00 | $8.63M | 575,000 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | C Conversion | 2021-04-27 | 2021-04-29 | 101,457 | $13.50 | $1.37M | 2,309,791 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | C Conversion | 2021-04-27 | 2021-04-29 | 500,932 | — | $0 | 1,849,456 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | C Conversion | 2021-04-27 | 2021-04-29 | 540,265 | — | $0 | 1,348,524 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | C Conversion | 2021-04-27 | 2021-04-29 | 808,259 | — | $0 | 808,259 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | J Other deriv | 2021-04-22 | 2021-04-26 | 1,359,799 | — | $0 | 1,359,799 | SEC↗ |
| CABA Cabaletta Bio, Inc. | S Sale | 2021-01-12 | 2021-01-12 | 74,470 | $13.00 | $968.1K | 2,614,575 | SEC↗ |
| CABA Cabaletta Bio, Inc. | S Sale | 2021-01-12 | 2021-01-12 | 10,530 | $13.00 | $136.9K | 369,688 | SEC↗ |
| CABA Cabaletta Bio, Inc. | S Sale | 2021-01-08 | 2021-01-12 | 37,411 | $13.00 | $486.3K | 380,218 | SEC↗ |
| CABA Cabaletta Bio, Inc. | S Sale | 2021-01-08 | 2021-01-12 | 264,589 | $13.00 | $3.44M | 2,689,045 | SEC↗ |
| AKUS Akouos, Inc. | S Sale | 2020-12-29 | 2020-12-31 | 358,352 | $18.00 | $6.45M | 3,153,331 | SEC↗ |
| AKUS Akouos, Inc. | S Sale | 2020-12-29 | 2020-12-31 | 111,648 | $18.00 | $2.01M | 982,453 | SEC↗ |
| CABA Cabaletta Bio, Inc. | S Sale | 2020-12-10 | 2020-12-14 | 36,916 | $14.75 | $544.5K | 417,629 | SEC↗ |
| CABA Cabaletta Bio, Inc. | S Sale | 2020-12-10 | 2020-12-14 | 261,084 | $14.75 | $3.85M | 2,953,634 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion deriv | 2020-06-30 | 2020-07-02 | 42,102,730 | — | $0 | 0 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion deriv | 2020-06-30 | 2020-07-02 | 21,072,595 | — | $0 | 0 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion deriv | 2020-06-30 | 2020-07-02 | 16,858,076 | — | $0 | 0 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion deriv | 2020-06-30 | 2020-07-02 | 10,826,417 | — | $0 | 0 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion | 2020-06-30 | 2020-07-02 | 999,980 | — | $0 | 3,511,683 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion | 2020-06-30 | 2020-07-02 | 799,984 | — | $0 | 799,984 | SEC↗ |
| AKUS Akouos, Inc. | P Buy | 2020-06-30 | 2020-07-02 | 294,117 | $17.00 | $5.00M | 1,094,101 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion | 2020-06-30 | 2020-07-02 | 1,997,946 | — | $0 | 2,511,703 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion | 2020-06-30 | 2020-07-02 | 513,757 | — | $0 | 513,757 | SEC↗ |
| CABA Cabaletta Bio, Inc. | C Conversion deriv | 2019-10-29 | 2019-10-31 | 1,675,532 | — | $0 | 0 | SEC↗ |
| CABA Cabaletta Bio, Inc. | C Conversion deriv | 2019-10-29 | 2019-10-31 | 3,146,551 | — | $0 | 0 | SEC↗ |
| CABA Cabaletta Bio, Inc. | P Buy | 2019-10-29 | 2019-10-31 | 454,545 | $11.00 | $5.00M | 454,545 | SEC↗ |
| CABA Cabaletta Bio, Inc. | C Conversion | 2019-10-29 | 2019-10-31 | 3,214,721 | — | $0 | 3,214,721 | SEC↗ |